Grant: Master's Award: Canada Graduate Scholarships
University of Guelph
$27,000.00
De novo design of mycobacterial proteasome binders
EF 2024-25
Résumé
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (Mtb) which represents a major global health challenge. A rise in drug-resistant strains is making current treatments less effective, underscoring the urgent need for new therapeutic strategies. One promising approach is to target the Mtb proteasome, a protein complex that plays a key role in helping Mtb evade the immune system.This project leverages recent advances in artificial intelligence (AI) and protein design to better understand how to effectively target the Mtb proteasome. Powerful new AI-based tools allow for the creation of entirely novel proteins from scratch. These tools could be employed to design proteins that specifically bind to unique regulatory sites on the Mtb proteasome, and potentially disrupt its function.We hypothesize that new AI-powered tools will enable the design of new proteins that bind to the Mtb proteasome. To test this, I have two main objectives.Firstly, I aim to design potential binders of the Mtb proteasome and screen them in the lab. Using AI tools, I will generate protein structures that target specific surfaces on the Mtb proteasome. Promising candidates will then be produced in bacteria and preliminary tests will be conducted to determine whether or not they bind the Mtb proteasome. Secondly, I aim to conduct a detailed investigation of initial hits. We will measure how strongly the binders interact with the Mtb proteasome and assess their basic biochemical properties. We will also determine if these binders can alter the proteasome's activity in ways that could weaken Mtb defenses.This research could help inform the development of new drugs specifically targeting drug-resistant TB, offering an innovative path forward in the fight against TB.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
530129
Name
Ogata-Bean Jacquelyn C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
De novo design of mycobacterial proteasome binders
Programtype2
Studentship Programs
Orgnameinp2
University of Guelph
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antibiotic Resistance; Protein Design; Tuberculosis
Abstract
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (Mtb) which represents a major global health challenge. A rise in drug-resistant strains is making current treatments less effective, underscoring the urgent need for new therapeutic strategies. One promising approach is to target the Mtb proteasome, a protein complex that plays a key role in helping Mtb evade the immune system.This project leverages recent advances in artificial intelligence (AI) and protein design to better understand how to effectively target the Mtb proteasome. Powerful new AI-based tools allow for the creation of entirely novel proteins from scratch. These tools could be employed to design proteins that specifically bind to unique regulatory sites on the Mtb proteasome, and potentially disrupt its function.We hypothesize that new AI-powered tools will enable the design of new proteins that bind to the Mtb proteasome. To test this, I have two main objectives.Firstly, I aim to design potential binders of the Mtb proteasome and screen them in the lab. Using AI tools, I will generate protein structures that target specific surfaces on the Mtb proteasome. Promising candidates will then be produced in bacteria and preliminary tests will be conducted to determine whether or not they bind the Mtb proteasome. Secondly, I aim to conduct a detailed investigation of initial hits. We will measure how strongly the binders interact with the Mtb proteasome and assess their basic biochemical properties. We will also determine if these binders can alter the proteasome's activity in ways that could weaken Mtb defenses.This research could help inform the development of new drugs specifically targeting drug-resistant TB, offering an innovative path forward in the fight against TB.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ogata-Bean, Jacquelyn C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~